Wu, Wei
Khan, Behram
Sharzehee, Mohammadali
Zhao, Shijia
Samant, Saurabhi
Watanabe, Yusuke
Murasato, Yoshinobu
Mickley, Timothy
Bicek, Andrew
Bliss, Richard
Valenzuela, Thomas
Iaizzo, Paul A.
Makadia, Janaki
Panagopoulos, Anastasios
Burzotta, Francesco
Samady, Habib
Brilakis, Emmanouil S.
Dangas, George D.
Louvard, Yves
Stankovic, Goran
Dubini, Gabriele
Migliavacca, Francesco
Kassab, Ghassan S.
Edelman, Elazer R.
Chiastra, Claudio
Chatzizisis, Yiannis S.
Funding for this research was provided by:
National Institutes of Health (R01 HL144690)
Dr. Vincent Miscia Cardiovascular Research Fund
Article History
Received: 25 January 2021
Accepted: 26 May 2021
First Online: 10 June 2021
Competing interests
: Yiannis S. Chatzizisis has received speaker honoraria, advisory board fees and a research grant from Boston Scientific Inc. and a research grant from Medtronic Inc. Dr Chatzizisis has a domestic patent and international patent pending for the invention entitled “Computational simulation platform for the planning of interventional procedures” (U.S. Patent No. 11,026,749 and International Application No. PCT/US2020/057304). Emmanouil S. Brilakis: Consulting/speaker honoraria from Abbott Vascular, American Heart Association (associate editor Circulation), Amgen, Biotronik, Boston Scientific, Cardiovascular Innovations Foundation (Board of Directors), CSI, Elsevier, GE Healthcare, InfraRedx, Medtronic, Siemens, and Teleflex; research support from Regeneron and Siemens. Shareholder: MHI Ventures. Francesco Burzotta: Speaker honoraria from Medtronic, Abbott and Abiomed. Timothy Mickley and Andrew Bicek are employees of Boston Scientific Inc. Richard Bliss is an employee of Medtronic Inc. All other authors have no relevant conflict of interests to disclose.